Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Are mesenchymal stem cells in rheumatoid arthritis the good or bad guys?

30 Apr 2015

Abstract excerpt

The advancements in our understanding of the inflammatory and immune mechanisms in rheumatoid arthritis (RA) have fuelled the development of targeted therapies that block cytokine networks and pathogenic immune cells, leading to a considerable improvement in the management of RA patients. Nonetheless, no therapy is curative and clinical remission does not necessarily correspond to non-progression of joint damage....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone and Joint Diseases
Share to Mesenchymal stem cell research
Share to Osteoarthritis Treatment and Mechanisms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25929877
DOI: 10.1186/s13075-015-0634-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Are mesenchymal stem cells in rheumatoid arthritis the good or bad guys?PMID 25929877Read ↗

Mesenchymal stem cells in rheumatology: a regenerative approach to joint repairSemantic proximity Read ↗

Mesenchymal stem cells in rheumatoid synovium: enumeration and functional assessment in relation to synovial inflammation level.Semantic proximity Read ↗

Review: progression and heterogeneity of multiple sources of mesenchymal stromal cells for the treatment of rheumatoid arthritisSemantic proximity Read ↗

Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis.Semantic proximity Read ↗

Characterization of fibroblast-like synoviocytes from the synovial fluid of patients affected by juvenile idiopathic arthritis.Semantic proximity Read ↗

Distinct subsets of synovial fibroblasts control cartilage destruction in joint diseases.Semantic proximity Read ↗

Synovial fibroblasts: key players in rheumatoid arthritisSemantic proximity Read ↗

Role of mesenchymal stem cells in osteoarthritis treatmentSemantic proximity Read ↗

Mesenchymal progenitor cells from non-inflamed versus inflamed synovium post-ACL injury present with distinct phenotypes and cartilage regeneration capacity.Semantic proximity Read ↗

New insights into the pathogenesis of rheumatoid arthritisSemantic proximity Read ↗

Mesenchymal Stem Cell: Keystone of the Hematopoietic Stem Cell Niche and a Stepping-Stone for Regenerative MedicineSemantic proximity Read ↗

Targeting pathogenic fibroblast-like synoviocyte subsets in rheumatoid arthritisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.